<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0005">
 <element-citation publication-type="journal" id="rf0005">
  <person-group person-group-type="author">
   <name>
    <surname>Alberti</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Beretta</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Piatti</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Karantzoulis</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Piatti</surname>
    <given-names>M.L.</given-names>
   </name>
   <name>
    <surname>Santoro</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Viganò</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Giovannelli</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Pirro</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Montisano</surname>
    <given-names>D.A.</given-names>
   </name>
   <name>
    <surname>Appollonio</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Ferrarese</surname>
    <given-names>C.</given-names>
   </name>
  </person-group>
  <article-title>Guillain-Barré syndrome related to COVID-19 infection</article-title>
  <source>Neurol. Neuroimmunol. Neuroinflamm.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1212/NXI.0000000000000741</pub-id>
 </element-citation>
</ref>
